| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Legal > Legal > Law Firm Staff: Are They Treated as Equals? |
|
Advice Pool - Law Firm Staff: Are They Treated as Equals?
I attended an awards party last week honoring the "Best" lawyers in the community. It was a nice affair. One of the winners wa According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product s a partner at a major national law firm. As I read his profile, I was struck by comments made about him by one of his law par ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in tners. “I think much of what makes [him] a good attorney is that which makes him a good person…[He] genuinely car lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. s about people, which would, of course, include his clients and co-workers. [He] is one of the highest-ranking partners in our here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe firm. But he knows all of the staff … by name and talks to them on a regular basis. More importantly, he talks to them and ev d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ryone else as an equal. I believe his egalitarian views make him more accessible and likeable to clients and juries.” ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ote> The comments are telling in so many ways: 1. The attorney is a great person and probably great to work with. 2. Why i easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi s it unusual that an attorney would ‘know all the staff by name and talk to them on a regular basis’? I believe one of the bi nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically gest problems in firms today is the perception of inequality between attorneys and staff. I do staff surveys during training s and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ eminars and I ask them what their biggest frustration is. Among the top 3 is ‘attorney attitudes toward staff’. In the eyes of ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi many staff members, the attorneys don’t treat them as valuable members of a team. Instead, they’re thought of as secondary pla ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a yers in the firm. But let’s be honest about this – staff can make or break a firm. However, that’s only one part of the equat dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ion. For everyone to truly work together, the attorney must think of his staff as a team and treat them as such. I find it ra cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin her sad that knowing all the staff by name and talking to them on a regular basis is considered unusual enough to comment on. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen In a perfect world, EVERY attorney (especially partners) would act in the same egalitarian fashion. After all, partners own th t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel business. As a business owner, I firmly believe in talking to my staff on a regular basis. I also find it fundamental that a ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust business owner take the time to find out employees’ talents and skills so that they’re fully utilized in the best manner possi y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ble. It’s well known in the human resources field that employees don’t stay at a firm because of pay; rather, it’s because th . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de y feel useful, fulfilled, and valued. It’s a shame that many attorneys don’t understand this fundamental concept. If they did, elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip I believe that the award-winning attorney's attitude and approach would be the rule rather than the exception. Copyright 200 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Taxes: The Plan Ahead, Not the Look Behind Attracting Wealth With The Use of An Affirmation Board This History of Transcription and Law Firm Productivity
|